|
Title
|
Published
|
Price
|
|
Infectious Disease Testing Market: US, Europe, Japan--Emerging Opportunities and Business Strategies
By: Venture Planning Group
The infectious disease testing market is one of the most rapidly growing segments of the in vitro diagnostics industry, and the greatest challenge facing suppliers in the 21st century. Among the main driving forces
|
more...
|
11/1/2009
|
$25,800.00
|
|
2009 Worldwide Diagnostics Market Research Bundle
By: Kalorama Information
What does the diagnostic market look like today, how is the continuing economic news effecting the market, and what are companies doing right now to prosper? This diagnostic industry market research bundle, with over
|
more...
Search inside this report
|
10/1/2009
|
$5,995.00
|
|
Global Molecular Diagnostics Market: Opportunities & Future Forecast
By: Renub Research
Report Details
Renub Research report titled “Global Molecular Diagnostics Market: Opportunities & Future Forecast” analysis the global molecular diagnostics market. This research report provides the global molecular diagnostics industry past present and future scenario.
|
more...
|
8/11/2009
|
$1,000.00
|
|
Infectious Disease Diagnostic Markets
By: Kalorama Information
The ubiquity of infections makes thier detection a healthcare priority and an ongoing opportunity for IVD companies. The aging of the population, and emerging threats - MRSA, swine flu, and others have had an
|
more...
Search inside this report
|
8/1/2009
|
$3,500.00
|
|
Bioarrays for Life Science Research, Diagnostics and Drug R&D
By: Takeda Pacific
This research report is about the worldwide bioarray tools, technologies and services market. Bioarrays are also known as DNA microarrays, protein arrays, or biochips. These key mainstream life science research products and services involve technologies
|
more...
|
8/1/2009
|
$2,495.00
|
|
Molecular Diagnostics Market: Trends and Opportunities
By: Koncept Analytics
Molecular diagnostics or the analysis of DNA and RNA at the molecular level - is a fast-growing market, driven by the growing understanding of the human genome. Although a small part of the In-Vitro Diagnostics
|
more...
Search inside this report
|
7/1/2009
|
$800.00
|
|
Nucleic Acid Amplification Life Science Dashboard™ Series 2
By: Percepta Associates, Inc.
Nucleic acid amplification is one of the most commonly performed molecular biology techniques and is a necessary precursor to a range of methods from gene cloning and site-directed mutagenesis to the quantitative analysis of gene
|
more...
Search inside this report
|
7/1/2009
|
$3,850.00
|
|
Innovations In In-Vitro Diagnostics: New Technologies, Growth Opportunities, And The Future Market Outlook
By: Business Insights
Innovations in In-Vitro Diagnostics New technologies, growth opportunities and the future market outlook Report Overview Clinical diagnostics is an attractive and growing industry, with the majority of major diagnostic companies experiencing sales growth of over 10% in
|
more...
Search inside this report
|
6/1/2009
|
$3,835.00
|
|
In Vitro Diagnostics Market Analysis 2009-2024
By: Visiongain
New innovative report discusses how the global IVD market will develop in light of commercial opportunities and high technological potential
In vitro diagnostics constitute an important, growing healthcare industry and market, one that is
|
more...
|
5/29/2009
|
$2,502.00
|
|
Strategic Analysis of the European Markets for Theranostics
By: Frost & Sullivan
This Frost & Sullivan research service titled Strategic Analysis of the European Markets for Theranostics provides a strategic analysis of the theranostics market in Europe. This research service focuses on the current scenario in the
|
more...
|
5/26/2009
|
$6,500.00
|
|
H1N1 (Swine Influenza) Market Assessment (Latest Data, Company Profiles, Implications for Immunoassays and Molecular Assays)
By: Kalorama Information
The outbreak of H1N1 (swine flu) highlighted the public health importance of improved testing techniques and providing market opportunities for manufacturers of diagnostic tests and other products related to the disease. These conclusions and
|
more...
Search inside this report
|
5/1/2009
|
$800.00
|
|
Nucleic Acid Testing: A Vehicle for Advancing Personalized Medicine
By: Decision Resources
Introduction
One of the fastest-growing segments of molecular diagnostics is nucleic acid testing (NAT). NAT is central to
the life sciences industry, to improved healthcare, and to personalized medicine. Tools based on NAT are used
|
more...
|
4/17/2009
|
$2,250.00
|
|
Who's Doing What in Molecular Diagnostics? - The Results of the Kalorama Information/Emmes Group Survey of U.S. Laboratories
By: Kalorama Information
From Kalorama Information a unique tool for assessing the diagnostic business today. Working in conjunction with premier diagnostic survey database Emmes Group, Kalorama Information presents the summarized results from a recent survey of a
|
more...
Search inside this report
|
4/1/2009
|
$4,995.00
|
|
The 2009 Report on Molecular Diagnostics: World Market Segmentation by City
By: Icon Group International, Inc.
This report was created for global strategic planners who cannot be content with traditional methods of segmenting world markets. With the advent of a “borderless world”, cities become a more important criteria in prioritizing markets,
|
more...
Search inside this report
|
1/5/2009
|
$795.00
|
|
The World Market for Molecular Diagnostics
By: Kalorama Information
Molecular diagnostics represents a revolution postponed, perhaps, but one that is now clearly underway. DNA Testing has emerged fully from research into clinical practice and becoming a dominant platform in clinical medicine.
|
more...
Search inside this report
|
1/1/2009
|
$3,995.00
|
|
Molecular Diagnostics: A Dynamic and Rapidly Broadening Market
By: CHI Insight Pharma Reports
Molecular diagnostic applications in the areas of oncology, personalized medicine, inherited disorders, prediction of genetic disease risk, and many others are rapidly increasing in number as this burgeoning field expands beyond infectious disease testing. This
|
more...
|
1/1/2009
|
$2,995.00
|
|
The 2009-2014 Outlook for Molecular Diagnostics in India
By: Icon Group International, Inc.
This econometric study covers the latent demand outlook for molecular diagnostics across the states, union territories and cities of India. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given
|
more...
Search inside this report
|
12/2/2008
|
$495.00
|
|
The 2009-2014 Outlook for Molecular Diagnostics in the United States
By: Icon Group International, Inc.
This econometric study covers the latent demand outlook for molecular diagnostics across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given
|
more...
Search inside this report
|
12/2/2008
|
$495.00
|
|
The 2009-2014 Outlook for Molecular Diagnostics in Greater China
By: Icon Group International, Inc.
This econometric study covers the latent demand outlook for molecular diagnostics across the regions of Greater China, including provinces, autonomous regions (Guangxi, Nei Mongol, Ningxia, Xinjiang, Xizang - Tibet), municipalities (Beijing, Chongqing, Shanghai, and Tianjin),
|
more...
Search inside this report
|
12/2/2008
|
$495.00
|
|
The 2009-2014 Outlook for Molecular Diagnostics in Japan
By: Icon Group International, Inc.
This econometric study covers the latent demand outlook for molecular diagnostics across the prefectures and cities of Japan. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across some
|
more...
Search inside this report
|
12/2/2008
|
$495.00
|
|
The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 6th Edition [with 2009 economy preface]
By: Kalorama Information
This edition of Kalorama’s comprehensive and indispensable report covers the breadth of traditional IVD testing. The report contains complete market statistics and analysis for all areas of IVD, including:
Point-of-Care
Core Lab
|
more...
Search inside this report
|
12/1/2008
|
$3,995.00
|
|
Molecular Diagnostics: a primer on an emerging sector
By: Datamonitor
Introduction This report analyzes the emerging sector of molecular diagnostics. It provides a clear classification, assessing the leading technologies and key tests which are positioned in this exciting area of diagnostics. The current MDx market size
|
more...
|
11/19/2008
|
$7,600.00
|
|
How to Integrate Personalized Medicine into Business Strategies
By: Decision Resources
Introduction
A growing awareness is taking hold across the pharmaceutical industry: what was once impossible—tailoring
treatment to specific groups of patients rather than to the population as a whole—is becoming possible. What
is
|
more...
|
9/24/2008
|
$2,250.00
|
|
U.S. Nucleic Acid Purification and Isolation Markets
By: Frost & Sullivan
This research service analyzes the market for nucleic acid purification and isolation products within the United States. The market was divided into the nucleic acid purification and isolation consumables and nucleic acid purification and isolation
|
more...
|
9/22/2008
|
$6,000.00
|
|
The 2009-2014 World Outlook for Molecular Diagnostics
By: Icon Group International, Inc.
This econometric study covers the world outlook for molecular diagnostics across more than 200 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in
|
more...
Search inside this report
|
9/20/2008
|
$795.00
|
|
Title
|
Published
|
Price
|
(0 items)
